JAK2 and neoplasm: JAK2-translocation neoplasms are of significant biologic and therapeutic interest, notably since their neoplastic signalling depends on a defined, druggable target,and is distinguished from the better understood JAK2617F-mutation disease by their greater clinical and protein-structural heterogeneity,.